7 Most Promising Biotech Stocks to Buy According to Hedge Funds
If there’s one sector that is gaining popularity each day, it’s definitely the biotechnology market.
Revolution Medicines Inc. (RVMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 14,325,692 | $527,042,209 | +6% | 2.27% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 9,364,972 | $344,537,320 | +18% | 3.34% |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 4,982,384 | $183,301,907 | 6.55% | |
| 4. | Holocene Advisors Brandon Haley | 3,632,952 | $133,656,304 | -2% | 0.33% |
| 5. | Deerfield Management James E. Flynn | 3,384,072 | $124,500,009 | +3% | 2.26% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $46.00 | 760,869 | $34,999,974.00 | 760,869 | 2024-12-05 | Filing | |
| $46.00 | 543,478 | $24,999,988.00 | 2,096,612 | 2024-12-05 | Filing | |
| $20.85 | 6,200 | $129,270.00 | 1,553,134 | 2023-03-10 | Filing | |
| $20.43 | 93,800 | $1,916,334.00 | 1,546,934 | 2023-03-10 | Filing | |
| $22.00 | 318,181 | $6,999,982.00 | 618,181 | 2023-03-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $44.26 | 1,799 | $79,623.74 | 50,425 | 2025-09-24 | Filing | |
| $45.82 | 2,160 | $98,981.78 | 88,339 | 2025-09-16 | Filing | |
| $45.82 | 5,367 | $245,942.24 | 284,047 | 2025-09-16 | Filing | |
| $45.82 | 13,411 | $614,557.73 | 452,309 | 2025-09-16 | Filing | |
| $45.82 | 4,775 | $218,813.90 | 145,900 | 2025-09-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,761,691 | $579,872,613 | 0.01% | |
| 2. | 10,590,727 | $389,682,579 | 0.19% | |
| 3. | 10,259,738 | $377,455,760 | 0.07% | |
| 4. | 8,661,393 | $318,652,648 | 0.01% | |
| 5. | 8,325,184 | $306,283,536 | 0.02% |
News See All
Oppenheimer Reaffirms Outperform on Revolution Medicines (RVMD) Amid RAS Therapy Progress
Revolution Medicines, Inc. (NASDAQ:RVMD) ranks among the best mid-cap stocks with huge upside potential.
12 Best Mid-Cap Stocks with Huge Upside Potential
The Commerce Department said on August 29 that core inflation, which does not include food and energy expenses, stood at a 2.9% seasonally adjusted annual rate based on the personal consumption expenditures...
13 Best Mid Cap Growth Stocks to Buy According to Hedge Funds
On August 26, Courtney Garcia, Payne Capital Management senior wealth advisor, joined CNBC television for an interview to discuss whether investors should continue buying in the current market scenario...
Piper Sandler Initiates Coverage of Revolution Medicines (RVMD) with an Overweight Rating
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the most promising future stocks according to Wall Street analysts. On August 18, Piper Sandler initiated coverage of Revolution Medicines, Inc.
12 Most Promising Future Stocks According to Wall Street Analysts
Stockton further stated that while breadth hasn’t been great, it hasn’t been terrible either, not being wholly related to the mega caps.
Revolution Medicines Receives FDA Breakthrough Therapy Designation for Elironrasib for Lung Cancer
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best upside stocks to invest in now.
11 Best Upside Stocks to Invest in Now
Earlier on July 17, Sharmin Mossavar-Rahmani, Goldman Sachs CIO of wealth management, joined 'Squawk Box' on CNBC to discuss the latest market trends, what to expect in H2 2025, the state of the economy...
Revolution Medicines, Inc. (NASDAQ:RVMD) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Revolution Medicines Q2 2025 Earnings Conference Call.
Revolution Medicines, Iambic Therapeutics Partner to Use AI for Novel RAS-Addicted Cancer Drug Discovery
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best mid cap pharma stocks to buy.
Hedge Fund Resource Center Billionaire Hedge Funds
